Figure 1

Characterization of BM-derived MSCs. Surface expression of CD29, CD90 and CD 34 of rat MSCs were monitored by FACS analysis. Percentage of cells expressing markers CD29, CD90 and CD34 were 98.6, 98.2, and 1.2%, respectively. FITC, fluorescein isothiocyanate.